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Introduction
There is an increased prevalence of Crohn’s disease
(CD) in familial Mediterranean fever (FMF). Previous
studies found that neither MEFV, nor NOD2/CARD15
may serve as susceptible genes, leading to FMF-CD
comorbidity. In addition to NOD2/CARD15 polymorph-
ism, ATG16L1 and IL-23R gene SNPs were also found
to predispose to Crohn’s disease (CD). The role of these
genes in the occurrence of FMF-CD is currently
unknown.
Objectives
To determine the role of polymorphism in NOD2,
ATG16L1 and IL-23R genes in FMF-CD, and character-
ize the clinical correlates of this association.
Methods
To enrich for CD associated genes with possible effect on
the occurrence of FMF-CD, we identified all patients with
FMF-CD in our computerized registry of approximately
12,000 FMF patients. All patients were tested for MEFV,
NOD2, ATG16L1 and IL-23R relevant gene mutations
and completed a questionnaire, detailing the phenotype of
their disease. CD diagnosis was established by typical clini-
cal, radiological and endoscopic findings, while a diagnosis
of FMF was determined based on our established set of
criteria.
Results
Nineteen patients with FMF-CD were identified. Of them,
17 consented to participate in this study (8 females, 9
males). All patients were of North-African origin. Ten
patients (58%) were carriers of the MEFV M694V
mutation (5 homozygous). Eight patients (47%) needed
biological treatment to control their CD. Two patients
(11.7%) had amyloidosis with chronic renal failure. When
compared to published patients with CD alone, the FMF-
CD group had comparable rate of Gly908Arg NOD2
mutation (19% vs. 9.8%, P=0.2), Thr300Ala ATG16L1
mutation (78% vs. 58%, p=0.14) but significantly increased
rate of the rs1004819 polymorphism in IL-23R (61% vs.
38%, p=0.006).
Conclusion
The rs1004819 IL-23R polymorphism predisposes for
the occurrence of FMF-CD. In patients with this comor-
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